Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality

PHASE4CompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

March 15, 2017

Primary Completion Date

October 31, 2017

Study Completion Date

August 2, 2018

Conditions
Coronary Artery Disease
Interventions
DRUG

Nitroglycerin

Patients grouped in sublingual administration (group 1 and 2) will receive Nitroglycerin during the cCTA scan by the MD after the Calcium scoring scan and 5 minutes before the actual cCTA scan. Patients categorized to transdermal administration will receive Nitroglycerin 1 hour before the CT examination. The patch will be placed on the chest or the upper arm.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT02961946 - Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality | Biotech Hunter | Biotech Hunter